OPAL - OHIO PRIVATE ACADEMIC LIBRARIES / Otterbein

LEADER 00000nam  2200385Ii 4500 
001    361875666 
003    OCoLC 
005    20090529122744.0 
006    m        d f       
007    cr an||||||||| 
008    090529s2001    mdu     s    f000 0 eng d 
040    GPO|beng|erda|cGPO|dMvI 
074    0499-T-02 (online) 
086 0  HE 20.4802:P 91/7 
086 0  HE 20.4802:P 91/7 
245 00 Guidance for FDA reviewers :|bpremarket notification 
       submissions for empty containers for the collection and 
       processing of blood and blood components. 
246 30 Premarket notification submissions for empty containers 
       for the collection and processing of blood and blood 
       components 
264  1 Rockville, MD :|bU.S. Dept. of Health and Human Services, 
       Food and Drug Administration, Center for Biologics 
       Evaluation and Research,|c[2001] 
300    i, 5 pages :|bdigital, PDF file 
336    text|btxt|2rdacontent 
337    computer|bc|2rdamedia 
338    online resource|bcr|2rdacarrier 
340    |gmonochrome|2rdacc|0http://rdaregistry.info/termList/
       RDAColourContent/1002 
500    Title from PDF title page (viewed on May 29, 2009). 
500    "July 2001". 
538    Mode of access: Internet at the FDA CBER web site. Address
       as of 5/29/08: http://www.fda.gov/cber/gdlns/
       pmacontain.pdf  ; current access is available via PURL. 
650  0 Containers|0http://id.loc.gov/authorities/subjects/
       sh85031520|xGovernment policy|0http://id.loc.gov/
       authorities/subjects/sh99005269|zUnited States.|0http://
       id.loc.gov/authorities/names/n78095330 
650  0 Blood|xCollection and preservation|0http://id.loc.gov/
       authorities/subjects/sh85014938|xGovernment policy|0http:/
       /id.loc.gov/authorities/subjects/sh99005269|zUnited 
       States.|0http://id.loc.gov/authorities/names/n78095330 
710 2  Center for Biologics Evaluation and Research (U.S.)|0http:
       //id.loc.gov/authorities/names/n88098944 
856 40 |uhttp://purl.access.gpo.gov/GPO/LPS113250